• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL1800021 奥卡替尼 alkotinib Active ingredient Chemical Drugs(1) New Drug Application 2018-02-26 苏州泽璟生物制药有限公司 Suzhou Zelgen Biopharmaceuticals Co Ltd In Review 2018-02-24 view
CXHL1800022 奥卡替尼胶囊 alkotinib Capsule Chemical Drugs(1) New Drug Application 2018-02-26 苏州泽璟生物制药有限公司 Suzhou Zelgen Biopharmaceuticals Co Ltd Certificate Issued 2018-06-08 view
CXHL1800023 奥卡替尼胶囊 alkotinib Capsule Chemical Drugs(1) New Drug Application 2018-02-26 苏州泽璟生物制药有限公司 Suzhou Zelgen Biopharmaceuticals Co Ltd Certificate Issued 2018-06-08 view